Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRANITE-1 granulocyte transfusions for febrile neutropenia
2009-010700-28Phase 3Terminated
- Sponsor
- University of Cologne
- Start
- Apr 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of granulocyte transfusion, filgrastim and lenograstim in febrile neutropenia (FN), sponsored by University of Cologne. Primary endpoint: Measurement of temperature. Started Apr 2010; status: terminated.
02
Drugs
granulocyte transfusionfilgrastimlenograstim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on 2009-010700-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010700-28.